A national organization of pediatricians and other health care professionals claims that “gender-affirming” therapies have not been shown to benefit adolescents with gender dysphoria.

The American College of Pediatricians (ACPeds), based in Florida, released a position statement on Feb. 7 stating that “social transition, puberty blockers and cross-sex hormones have no demonstrable, long-term benefit on the psychosocial well-being of adolescents with gender dysphoria.”

“A review of at least 60 research papers demonstrates no benefit to social affirmation, puberty blockers, cross-sex hormones or surgical interventions for these youth,” lead author and vice president of ACPeds, Dr. Jane Anderson, wrote in an email to Fox News Digital.

Fox News Digital reached out to the AMA, OASH and the American Academy of Pediatrics requesting comment on the ACPeds study.

For more Health articles, visit www.foxnews.com/health.

Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to [email protected].